Zacks Research Brokers Boost Earnings Estimates for Clorox

The Clorox Company (NYSE:CLXFree Report) – Investment analysts at Zacks Research boosted their Q4 2026 earnings per share (EPS) estimates for Clorox in a research report issued to clients and investors on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.18 for the quarter, up from their prior estimate of $1.90. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 EPS.

CLX has been the topic of several other reports. Barclays raised their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. DA Davidson cut their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Wells Fargo & Company raised their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Read Our Latest Research Report on Clorox

Clorox Trading Up 1.2 %

NYSE:CLX opened at $152.93 on Thursday. The business’s 50-day moving average is $158.11 and its two-hundred day moving average is $159.68. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market capitalization of $18.84 billion, a PE ratio of 41.78, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42.

Institutional Trading of Clorox

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Insight Folios Inc increased its holdings in Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after buying an additional 63 shares during the last quarter. Integral Investment Advisors Inc. increased its holdings in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after buying an additional 67 shares during the last quarter. HCR Wealth Advisors increased its holdings in Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC increased its holdings in Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after buying an additional 77 shares during the last quarter. Finally, Empower Advisory Group LLC increased its holdings in Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.